Lead party: SAB Foundation (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: LIQID Medical (Pty) Ltd
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Deal amount: US$1.8m
Investors/buyers: SAB Foundation
Legal advisers: not identified in the source record.
Source: announced 28 November 2022. Original announcement: ventureburn.com.


